Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
#Hemoglobin A1c Testing Devices Market Expansion Outlook: What Revenue Opportunities Are Ahead?#_x000D_
The hemoglobin a1c testing devices market has expanded rapidly in recent years. It is projected to grow from $2.08 billion in 2025 to $2.32 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.7%. This historic growth can be attributed to the increasing prevalence of diabetes, the wider adoption of routine blood glucose monitoring practices, improved availability of laboratory diagnostics, growing awareness regarding glycemic control, and the implementation of standardized diabetes testing protocols._x000D_
_x000D_
The market for hemoglobin a1c testing devices is projected for substantial growth in the upcoming years. This market is anticipated to reach $3.53 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 11.1%. Several factors are driving this expansion during the forecast period, including a heightened demand for home-based diabetes monitoring, greater integration of AI-driven analytics, the broadening scope of remote patient monitoring, an increasing emphasis on personalized diabetes care, and the wider adoption of smart diagnostic devices. Key trends projected for this period involve a surge in point-of-care HbA1c testing, the expanding utilization of portable and handheld devices, deeper integration with digital diabetes management platforms, the development of rapid and highly accurate assays, and an increased focus on patient-centric monitoring._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Hemoglobin A1c Testing Devices Market Opportunity Drivers: What’s Unlocking New Revenue Potential?#_x000D_
The increasing occurrence of diabetes is anticipated to stimulate growth in the hemoglobin A1C testing devices market. Diabetes is a chronic metabolic condition characterized by elevated blood glucose levels. Hemoglobin A1C testing provides insights into average blood glucose levels in individuals, which is instrumental in the diagnosis of type 2 diabetes, pre-diabetes, and in diabetes management, enabling individuals to monitor their condition and make informed treatment decisions to prevent complications. For instance, in June 2024, the National Health Service, a UK-based government department, reported that in 2023, the NHS identified over half a million (549,000) new individuals in England at risk of developing type 2 diabetes. This increased the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This marks a significant rise compared to 3,065,825 in 2022, reflecting an increase of nearly 20%. Therefore, the growing number of diabetes patients will propel the hemoglobin A1C testing devices market._x000D_
_x000D_
#Hemoglobin A1c Testing Devices Market Segment Outlook: Which Categories Are Growing Fastest?#_x000D_
The hemoglobin a1c testing devices market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Bench Top Device, Handheld Device_x000D_
2) By Technology: Ion-Exchange HPLC, Immunoassay, Boronate Affinity Chromatography, Direct Enzymatic Assay, Other Technologies_x000D_
3) By End Use: Hospitals, Pharmaceuticals, Medical Devices, Laboratory Testing_x000D_
_x000D_
Subsegments:_x000D_
1) By Bench Top Device: Automated Hemoglobin A1C Analyzers, Laboratory-Grade Analyzers, Multi-Parameter Testing Devices _x000D_
2) By Handheld Device: Portable Hemoglobin A1C Testers, Point-Of-Care Testing Devices, Smartphone-Integrated Testing Devices _x000D_
_x000D_
#Hemoglobin A1c Testing Devices Market Innovation Trends Shaping Future Development#_x000D_
Major companies operating in the hemoglobin A1c testing devices market are concentrating on developing innovative solutions, such as at-home or micro-sample HbA1c collection kits, to address the increasing demand driven by rising diabetes prevalence, the shift towards decentralized care and telehealth, and patients’ preference for convenient, lower-cost monitoring options. An at-home HbA1c collection kit is a user-friendly system enabling a patient to perform a small finger-prick blood collection (typically a few drops), stabilize the micro-sample for transport, and dispatch it to a certified laboratory for highly accurate analysis. For instance, in February 2023, Hurdle, a US-based diagnostics-as-a-service company, launched the Hemoglobin A1c (HbA1c) Test, an at-home HbA1c test available through its Chronomics direct-to-consumer store. This Hemoglobin A1c Test is supplied as a home collection kit that includes finger-prick lancets and a sample card/tube, secure registration via a personal dashboard, and courier return to partner CLIA-certified labs; the service promises lab-grade analysis with a typical turnaround of about three days after lab receipt, integrated result explanations, and optional one-to-one access to healthcare professionals for follow-up, thereby combining the convenience of point-of-care or home sampling with the accuracy and standardization of central laboratory assays._x000D_
_x000D_
#Hemoglobin A1c Testing Devices Market Leading Players And Competitive Positioning#_x000D_
Major companies operating in the hemoglobin a1c testing devices market are Arkray Inc, Abbott Laboratories, Polymer Technology Systems Inc, Bio-Rad Laboratories Inc, Menarini Group, F Hoffmann-La Roche AG, Siemens Healthineers AG, Tosoh Corporation, Trinity Biotech plc, Transasia Bio-Medicals Limited, Beckman Coulter Inc, Diazyme Laboratories Inc, EKF Diagnostics Holdings plc, HemoCue AB, OSANG Healthcare Co Ltd, Danaher, Thermo Fisher Scientific Inc., PTS Diagnostics India Private Limited, Nova Biomedical, Randox Laboratories Ltd., ACON Laboratories Inc., DiaSys Diagnostic Systems GmbH, Erba Mannheim, Green Cross Medical Science Corp., Infopia Co. Ltd., TaiDoc Technology Corporation, Werfen, Zhejiang Orient Gene Biotech Co. Ltd. _x000D_
_x000D_
#View The Full Hemoglobin A1c Testing Devices Market Report:#_x000D_
_x000D_
#Hemoglobin A1c Testing Devices Market Regional Distribution: Which Areas Power Market Growth?#_x000D_
North America was the largest region in the hemoglobin A1C testing devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the hemoglobin A1C testing devices market during the forecast period. The regions covered in the hemoglobin a1c testing devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.